Activating Compound | Comment | Organism | Structure |
---|---|---|---|
benzbromarone | MRP2-mediated transport of amphipathic lipophilic drugs | Homo sapiens | |
diclofenac | MRP2-mediated transport of amphipathic lipophilic drugs, stimulates paclitaxel, docetaxel, and saquinavir transport | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
enzyme expression in MDCK II cells | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
benzbromarone | - |
Homo sapiens | |
diclofenac | inhibits MRP2-mediated drug transport | Homo sapiens | |
elacridar | inhibits P-gp | Canis lupus familiaris | |
additional information | inhibition kinetics, overview | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Homo sapiens | 16020 | - |
membrane | - |
Canis lupus familiaris | 16020 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | - |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + methotrexate/in | Canis lupus familiaris | - |
ADP + phosphate + methotrexate/out | - |
? | |
ATP + H2O + xenobiotic/in | Homo sapiens | - |
ADP + phosphate + xenobiotic/out | - |
? | |
ATP + H2O + xenobiotic/in | Canis lupus familiaris | - |
ADP + phosphate + xenobiotic/out | - |
? | |
additional information | Homo sapiens | stimulation of elimination via MRP2 may result in suboptimal chemotherapeutic drug concentrations, and stimulation of MRP2 activity in tumors may lead to increased efflux of chemotherapeutic drugs and thereby drug resistance | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Canis lupus familiaris | - |
- |
- |
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
MDCK II cell | - |
Canis lupus familiaris | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + diclofenac/in | substrate of BCRP, but not of P-gp and MDR1 | Homo sapiens | ADP + phosphate + diclofenac/out | - |
? | |
ATP + H2O + docetaxel/in | - |
Homo sapiens | ADP + phosphate + docetaxel/out | - |
? | |
ATP + H2O + methotrexate/in | - |
Homo sapiens | ADP + phosphate + methotrexate/out | - |
? | |
ATP + H2O + methotrexate/in | - |
Canis lupus familiaris | ADP + phosphate + methotrexate/out | - |
? | |
ATP + H2O + paclitaxel/in | - |
Homo sapiens | ADP + phosphate + paclitaxel/out | - |
? | |
ATP + H2O + saquinavir/in | - |
Homo sapiens | ADP + phosphate + saquinavir/out | - |
? | |
ATP + H2O + xenobiotic/in | - |
Homo sapiens | ADP + phosphate + xenobiotic/out | - |
? | |
ATP + H2O + xenobiotic/in | - |
Canis lupus familiaris | ADP + phosphate + xenobiotic/out | - |
? | |
additional information | stimulation of elimination via MRP2 may result in suboptimal chemotherapeutic drug concentrations, and stimulation of MRP2 activity in tumors may lead to increased efflux of chemotherapeutic drugs and thereby drug resistance | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ABCB1 | - |
Homo sapiens |
ABCC2 | - |
Homo sapiens |
ABCG2 | - |
Homo sapiens |
BCRP | - |
Homo sapiens |
breast cancer resistance protein | - |
Homo sapiens |
MDR1 | - |
Homo sapiens |
MRP2 | - |
Homo sapiens |
MRP2 | - |
Canis lupus familiaris |
multidrug resistance protein 2 | - |
Homo sapiens |
P-glycoprotein | - |
Homo sapiens |
P-gp | - |
Homo sapiens |
P-gp | - |
Canis lupus familiaris |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
5.5 | 7.4 | assay at pH 5.5 or pH 7.4 | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens | |
ATP | - |
Canis lupus familiaris |